Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors

BACKGROUND: Human papilloma virus (HPV) has been associated with the development and modulation of response in a series of neoplasms. In the case of lung adenocarcinoma, its role in etiology and pathogenesis is still controversial. Considering that this infection brings foreign epitopes, it could be...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, L., Mayorga, D., Ruiz-Patiño, A., Rodríguez, J., Cardona, A.F., Archila, P., Avila, J., Bravo, M., Ricaurte, L., Sotelo, C., Arrieta, O., Zatarain-Barrón, Z.L., Carranza, H., Otero, J., Vargas, C., Barrón, F., Corrales, L., Martín, C., Recondo, G., Pino, L.E., Bermudez, M.A., Gamez, T., Ordoñez-Reyes, C., García-Robledo, J.E., de Lima, V.C., Freitas, H., Santoyo, N., Malapelle, U., Russo, A., Rolfo, C., Rosell, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434139/
https://www.ncbi.nlm.nih.gov/pubmed/35753086
http://dx.doi.org/10.1016/j.esmoop.2022.100500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434139/
https://www.ncbi.nlm.nih.gov/pubmed/35753086
http://dx.doi.org/10.1016/j.esmoop.2022.100500

Ejemplares similares